Lb Pharmaceuticals LBRX
NASDAQ LBRX
$36.99 -0.29 (-0.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lb Pharmaceuticals (LBRX) Change in Accured Expenses (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) recorded Change in Accured Expenses of $12.54 million in Q2 2026, compared with -$1.55 million a year earlier and up 262.1% from the prior quarter.

Analysis

Lb Pharmaceuticals (LBRX) Change in Accured Expenses (2024 - 2026) Analysis & Trends

On a TTM basis, Lb Pharmaceuticals' Change in Accured Expenses came in at $19.54 million as of Jun 30, 2026; for FY2025, it came in at -$910,000.

  • Across earlier years, Change in Accured Expenses came in at $5.02 million in FY2024.
  • Per Business Quant, the preceding three quarters came in at $3.46 million (Q1 2026), $1.97 million (Q4 2025) and $1.57 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Lb Pharmaceuticals 1.06 Bn 1.06 Bn - 12.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.54 Mn
Mar 31, 2026 3.46 Mn
Dec 31, 2025 1.97 Mn
Sep 30, 2025 1.57 Mn
Jun 30, 2025 -1.55 Mn
Mar 31, 2025 -2.89 Mn
Dec 31, 2024 -2.93 Mn
API Access

Lb Pharmaceuticals Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=LBRX&period=max&api_key=YOUR_API_KEY